FDA: Tariffs threaten lifesaving heparin supply

With the recent tariffs imposed by President Donald Trump, experts are warning that new trade barriers could jeopardize the supply of heparin, an inexpensive and widely used anticoagulant critical for millions of hospitalized patients, The Washington Post reported April 13. Wanda Crowell, a cancer survivor receiving daily infusions at Johns Hopkins Hospital in Baltimore, [...] The post Tariffs threaten lifesaving heparin supply appeared first on Becker's Hospital Review | Healthcare News & Analysis.